• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

ASP Isotopes Shares Tumble on Fuzzy Panda Research Report

by November 26, 2024
written by November 26, 2024

On Tuesday, shares of ASP Isotopes (ASPI) plummeted by 20% following a critical report from Fuzzy Panda Research. The report alleges that ASPI is utilizing outdated laser enrichment technology and is connected to individuals previously charged with securities fraud.

Fuzzy Panda Research claims that ASPI is masquerading as a new, innovative Uranium enrichment company while in reality, it is leveraging old and uneconomic technology. The report cites conversations with former executives from customers and competitors who have deemed ASPI’s technology virtually worthless. It further states that ASPI’s technology was once considered for acquisition by Centrus, but was rejected as it was not valued even at $2 million.

The report also mentions an array of concerns, including ASPI’s lack of patents, with the company claiming that patents would be detrimental and that their process is a trade secret. Additionally, it highlights the company’s questionable history, noting that it was incorporated in September 2021 and funded shortly after by a shell company with connections the individuals previously charged with securities fraud.

The investigation by Fuzzy Panda Research could not locate multiple ASPI subsidiaries at their registered addresses in South Africa. Furthermore, the report states that ASPI’s AVLIS technology, which involves the laser enrichment of uranium, has been scrapped by twenty governments after decades of research due to its lack of economic viability.

Experts have also expressed doubts about ASPI’s ability to obtain an NRC license to enrich Uranium, a process that could take up to 15 years. They have also contested the company’s cost estimates for building facilities, suggesting that the actual costs could run into the billions, as opposed to ASPI’s claim of less than $10 million.

The report concludes by asserting that ASP Isotopes might be the most egregious case yet of a paid stock promotion based on outdated technology, with a history of government research indicating that the technology is commercially nonviable.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
More Tesla jobs to leave California after Musk vs. Newsom battle, Wedbush says
next post
Greece stocks higher at close of trade; Athens General Composite up 0.13%

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • China outlines more controls on exports of rare earths and technology

      October 10, 2025
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

      October 7, 2025
    • YouTube to pay $24 million to settle Trump lawsuit

      October 1, 2025
    • Charlie Javice sentenced to 7 years in prison for fraudulent $175M sale of aid startup

      October 1, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (651)
    • Stock (6,426)

    Latest News

    • China outlines more controls on exports of rare earths and technology
    • Paramount acquires Bari Weiss’ The Free Press, naming her the top editor of CBS News

    Popular News

    • Brazil securities regulator accuses eight former Americanas executives of insider trading
    • US money market funds draw sharp inflows in the week to Oct. 2

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy